Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | YAP1 | P46937 | 15/20 | 0.68 |
| ▸ | CCR2 | P41597 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21359119 | 0.92 | YAP1 (0.64) | YAP1CCR2POLB | |
| SCHEMBL28499424 | 0.92 | YAP1 (0.64) | YAP1CCR2POLB | |
| SCHEMBL19982266 | 0.90 | YAP1 (0.79) | YAP1 | |
| SCHEMBL30117577 | 0.90 | YAP1 (0.79) | YAP1 | |
| SCHEMBL23296268 | 0.88 | YAP1 (0.87) | YAP1 | |
| SCHEMBL19974548 | 0.88 | YAP1 (0.87) | YAP1 | |
| SCHEMBL21366295 | 0.87 | YAP1 (0.63) | YAP1CCR2POLB | |
| SCHEMBL21359002 | 0.87 | YAP1 (0.63) | YAP1CCR2POLB | |
| SCHEMBL21359034 | 0.87 | YAP1 (0.63) | YAP1CCR2POLB | |
| SCHEMBL28499426 | 0.87 | YAP1 (0.63) | YAP1CCR2POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3512839-A1 | YAP1 INHIBITORS THAT TARGET THE INTERACTION OF YAP1 WITH OCT4 | H. Lee Moffitt Cancer Center And Research Institute, Inc. (US) | 2019-07-24 | — | — | EP | disclosed |
| WO-2018053446-A1 | YAP1 INHIBITORS THAT TARGET THE INTERACTION OF YAP1 WITH OCT4 | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. (US) | 2018-03-22 | — | — | WO | disclosed |